Literature DB >> 1685671

A novel subpopulation of CD45RA+ CD4+ T cells expressing IL-2 receptor alpha-chain (CD25) and having a functionally transitional nature into memory cells.

H Kanegane1, T Miyawaki, K Kato, T Yokoi, T Uehara, A Yachie, N Taniguchi.   

Abstract

Differential expression of various isoforms of leukocyte common antigen (CD45), which arises from alternate mRNA splicing, identifies naive and memory populations of human T cells. Some memory (CD45RO+ CD45RA-) populations of CD4+ T cells from adult individuals express IL-2 receptor (IL-2R) alpha-chain (CD25), but naive (CD45RO- CD45RA+) CD4+ T cells only do so to a small degree. We found that a small but significant fraction of CD4+ T cells in neonatal blood expressed CD25, although most generally exhibited the phenotype of naive cells. It was demonstrated that purified neonatal CD25+ CD4+ T cells expressed mRNA for the IL-2R alpha-chain. Two-color immunofluorescence analysis disclosed that a CD25+ population of neonatal CD4+ T cells had the naive (CD45RA+ CD45RO-) phenotypes. These CD25+ CD4+ T cells from newborns could express mRNA for some specified lymphokines such as IL-4, IL-5, and interferon-gamma on activation in a similar manner to CD45RO+ (memory) CD4+ T cells from adults. Notably, polymerase chain reaction analysis demonstrated that neonatal CD45RA+ CD4+ T cells expressing CD25 contained spliced mRNA transcripts possibly encoding CD45RO in addition to CD45RA-associated transcripts, seemingly indicating that this population might be in the recently antigen-primed states. Such a small population of CD45RA+ CD4+ T cells expressing CD25 appeared to be present in the blood throughout human life. The results suggest that CD4+ T cells with the naive (CD45RA+) phenotype expressing IL-2R alpha-chain (CD25) represent the novel transitional population in the maturation process of naive into memory CD4+ T cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685671     DOI: 10.1093/intimm/3.12.1349

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine-producing memory CD4+ T cells.

Authors:  H Kanegane; Y Kasahara; Y Niida; A Yachie; S Sughii; K Takatsu; N Taniguchi; T Miyawaki
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Differential expression of cytokine genes in CD27-positive and -negative CD4 lymphocyte subsets from healthy humans and rheumatoid arthritis patients.

Authors:  I Stonãns; E Stonãne; H Vogelsang; U Junker; L Jäger
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Inflammation-induced changes in the phenotype and cytokine profile of cells migrating through skin and afferent lymph.

Authors:  P J Egan; W Kimpton; H F Seow; V M Bowles; M R Brandon; A D Nash
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

4.  Delineation of producing ability of IgG and IgA subclasses by naive B cells in newborn infants and adult individuals.

Authors:  A Yachie; A Konno; K Ohta; T Wada; H Seki; N Taniguchi; T Miyawaki
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

5.  Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood.

Authors:  Kajsa Wing; Ann Ekmark; Helen Karlsson; Anna Rudin; Elisabeth Suri-Payer
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

6.  Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells.

Authors:  A M Verhagen; M R Brandon; A D Nash
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

7.  Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.

Authors:  D Dieckmann; H Plottner; S Berchtold; T Berger; G Schuler
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

Review 8.  Targeting regulatory T cells to improve vaccine immunogenicity in early life.

Authors:  Jorjoh Ndure; Katie L Flanagan
Journal:  Front Microbiol       Date:  2014-09-11       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.